baber/WOPTO huggingface dataset:
Patent DK-360286-A (DK)
Inventor: LAFON LOUIS
IPC: C07D241/04
Filed: 1986-07-29
Abstract: 1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A derivative belonging to the family of substituted phenylpiperazines selected from the group comprising : 1) 3-methyl-2-phenylpiperazine, 2) 1-isopropyl-3-phenylpiperazine, 3) 1-ethyl-2-methyl-3-phenylpiperazine, 4) 1-isopropyl-2-methyl-3-phenylpiperazine, 5) 1,2,4-trimethyl-3-phenylpiperazine, 6) (halogenophenyl)alkylpiperazines which have, in their molecule a halogen atom present on the phenyl ring and at least one alkyl group present on the piperazinyl ring, and which correspond to the general formula : (Io )   see diagramm : EP0211746,P19,F3   wherein X0 is F, Cl or Br and R1 , R2 and R3 are as defined above, with the additional proviso that at least one of the symbols R1 , R2 and R3 is different from H, and 7) addition salts thereof. 1. Claims for the Contracting State : AT A method for the preparation of a compound belonging to the phenylpiperazine family and selected from the group consisting of compounds of the formula (I)   see diagramm : EP0211746,P21,F2   wherein : (a) X = R1 = R3 = H, and R2 = CH3 ; (b) X = R2 = R3 = H, and R1 = CH(CH3 )2 ; (c) X = R3 = H, R1 = CH2 CH3 , and R2 = CH3 ; (d) X = R3 = H, R1 = CH(CH3 )2 , and R2 = CH3 ; (e) X = H, and R1 = R2 = R3 = CH3 ; (f) X = F, Cl, or Br, R1 is H or C1 -C4 alkyl, R2 is H, or C1 -C4 alkyl, and R3 is H or C1 -C4 alkyl, with the additional proviso, with respect to said item (f), that at least one of the R1 , R2 and R3 is different from H ; and (g) addition salts thereof ; said method being characterized in that it comprises A) reacting a 1-phenylalkane-1,2-dione of the formula : (II)   see diagramm : EP0211746,P21,F3   wherein X and R2 are defined as above with ethylenediamine : (III) H2 NCH2 CH2 NH2 to give a 2-phenyldihydropyrazine of the formula : (IV)   see diagramm : EP0211746,P22,F1   wherein X and R2 are defined as above ; B) subjecting the resulting compound of the formula IV to a reduction reaction with a reducing agent, selected in particular from the group comprising LiAlH4 , and NaBH4 , to give a 2-phenylpiperazine of the formula I, wherein R1 = R3 = H ; and C) if necessary, subjecting the resulting compound of the formula I wherein R1 = R3 = H to an alkylation reaction in order to introduce the group R1 = C1 -C4 alkyl or the groups R1 and R3 each representing a C1 -C4 alkyl group.
Patent DK-401689-A (DK)
Inventor: CLAUSEN HANS JACOB
IPC: C02F11/13
Filed: 1989-08-16
Abstract: In order to produce a thoroughly pasteurized growth substrate or manure the raw material is brought to pass through a perforated, tubular heating kiln (28), in which it is heated to some 90-100 DEG C, this being a dangerously high temperature with respect to ignition of the material and the gases developed therefrom. For eliminating the ignition risk the inlet and outlet ends of the tubular kiln (28) are blocked for entrance of atmospheric air, such that the atmosphere inside the kiln is maintained highly humid and low on oxygen. <IMAGE>
Patent DK-415984-A (DK)
Inventor: RIMBAULT CHRISTIAN GERARD
IPC: C07D335/06
Filed: 1984-08-30
Abstract: The invention relates to pharmaceutical preparations containing compounds of formula Iin which X represents unsubstituted or substituted amino or a quaternary ammonium salt; halogen, free, etherified or esterified hydroxy; free, etherified, esterified or oxidized mercapto; free or functionally modified carboxyl, free or functionally modified sulfo; acyl; nitro; an unsubstituted or substituted hydrocarbon radical or an unsubstituted or substituted heterocyclic radical, Y represents oxygen, sulfur, sulfinyl or sulfonyl but must be oxygen, sulfinyl or sulfonyl, if X is 1H-imidazol-1-yl, and rings A and B are each unsubstituted or substituted; or pharmaceutically acceptable salts of such compounds that contain a salt-forming group, and to novel compounds of formula I. The compounds are useful e.g. for the treatment of diseases of the respiratory tract and of liver diseases. They are prepared by methods known per se.
Patent DK-443881-A (DK)
Inventor: STEINER G
IPC: C07D495/14
Filed: 1981-10-07
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A 5-substituted 9-cyanomethylene-dithieno-[3,4-b:4',3'-e]azepine of the general formula I  see diagramm : EP0050212,P13,F1  where R**1 and R**2 are hydrogen or halogen, especially chlorine or bromine, and A is -NR**3 R**4 , where R**3 and R**4 , together with the nitrogen atom linking them, are a 5-membered to 7-membered saturated ring, which may contain nitrogen or oxygen as a further hetero-atom, an additional nitrogen present being unsubstituted or substituted by alkyl of 1 to 3 carbon atoms, hydroxyalkyl of 2 or 3 carbon atoms, alkoxyalkyl, where alkyl and alkoxy are of 1 to 3 carbon atoms, cycloalkyl or cycloalkylmethyl, where cycloalkyl is of 3 to 7 carbon atoms or alkynyl of 2 to 5 carbon atoms, and may additionally be substituted by oxygen in the form of an N-oxide, or A is -NHR**5 , where R**5 is aminoalkyl of 2 to 7 carbon atoms, the amine nitrogen being unsubstituted or substituted by lower alkyl of 1 to 5 carbon atoms or being a constituent of a 5-membered to 7-membered saturated ring, which may contain nitrogen or oxygen as a further hetero-atom, a nitrogen present being substituted by lower alkyl of 1 to 3 carbon atoms or hydroxyalkyl of 2 or 3 carbon atoms, and its physiologically tolerated acid addition salts. 1. Claims for the Contracting State : AT A process for the preparation of a 5-substituted 9-cyanomethylene-dithieno-[3,4-b:4'.3'-e]azepine of the general formula I  see diagramm : EP0050212,P14,F1  where R**1 and R**2 are hydrogen or halogen, especially chlorine or bromine, and A is -NR**3 R**4 , where R**3 and R**4 , together with the nitrogen atom linking them, are a 5-membered to 7-membered saturated ring, which may contain nitrogen or oxygen as a further hetero-atom, an additional nitrogen present being unsubstituted or substituted by alkyl of 1 to 3 carbon atoms, hydroxyalkyl of 2 or 3 carbon atoms, alkoxyalkyl, where alkyl and alkoxy are of 1 to 3 carbon atoms, cycloalkyl or cycloalkylmethyl, where cycloalkyl is of 3 to 7 carbon atoms or alkynyl of 2 to 5 carbon atoms, and may additionally be substituted by oxygen in the form of an N-oxide, or A is -NHR**5 , where R**5 is aminoalkyl of 2 to 7 carbon atoms, the amine nitrogen being unsubstituted or substituted by lower alkyl of 1 to 5 carbon atoms or being a constituent of a 5-membered to 7-membered saturated ring, which may contain nitrogen or oxygen as a further hetero-atom, a nitrogen present being substituted by lower alkyl of 1 to 3 carbon atoms or hydroxyalkyl of 2 or 3 carbon atoms, and its physiologically tolerated acid addition salts, wherein a compound of the formula II see diagramm : EP0050212,P14,F2  where R**1 and R**2 have the meanings given in the case of formula I and Z is a nucleofugic leaving group, is reacted with a nucleophile AH, where A has the meanings given in the case of formula I, and, if desired, the resulting compound is converted into the N-oxide and/or into the acid addition salt of a physiologically tolerated acid.
Patent DK-480387-A (DK)
Inventor: AGHAJANIAN MICHAEL K
IPC: C22C29/12
Filed: 1987-09-15
Abstract: A ceramic body is formed of alumina obtd. by oxidn. of molten aluminium with an oxygen-contg. gas under such conditions that the product remains in contact with the metal to form a body through which metal is continuously drawn to the oxidant interface to cause growth of the body. The body may also include non-oxidised metal components. - The body is caused to have a refined microstructure by including a process modifier either in the molten metal or in contact with it. - In a modification a body of filler is located adjacent to the metal bath so that it becomes embedded in the oxidn. product. Pref. the modifier is Cu, Ni, Fe, Zr, Cr, Ti, W, Nb or Co. - The modifier is pref. used in an amt. of 0.1-10 wt.% based on the aluminium metal. It may be alloyed with the latter, applied as a powder to the growth surface of the initial aluminium body, or mixed with the filler, which may be silicon carbide. (Dwg.0/3)
Patent DK-529789-A (DK)
Inventor: GOEBEL ROLAND
IPC: A61K6/884
Filed: 1989-10-25
Abstract: Dental metal/synthetic resin composite articles which adhere strongly, are resilient and stable to moisture can be prepared from dental alloys and synthetic resins when an adhesion-promoter layer which displays a concentration gradient and is composed of silicon dioxide and metal oxide, especially chromium oxide, is arranged between them.
Patent DK-565789-A (DK)
Inventor: HAAG HELMUT
IPC: H02G15/14
Filed: 1989-11-10
Abstract: In the case of a pressure-proof sleeve for connecting two cables having two half-shells, by means of which a cavity for splice reception is constructed, having transition pieces for the cable ends, which are placed on an inner cable sheath, and clips for clamping on the armouring wires or strain relief elements, it is provided that the transition pieces are constructed as corrugated tubes and are arranged over the conically constructed ends of the divided sleeve and the de- sheathed ends of the cable, that a first shrink-on collar is applied which extends over the sleeve and the corrugated tubes and closes sealingly against the inner cable sheath, that the strain relief elements are distributed over the circumference of the first shrink-on collar, that there are provided in each case at the ends of the cone and in the middle of the sleeve clips which non-positively connect the strain relief elements to the sleeve, and that a second shrink-on collar is applied over the entire structure.
Patent DK-682288-A (DK)
Inventor: HERMECZ ISTVAN
IPC: A61P31/04
Filed: 1988-12-07
Abstract: The invention relates to a new process for the preparation of compounds of the general Formula I  (* CHEMICAL STRUCTURE *) (I) wherein R stands for piperazinyl, 4-methyl-piperazinyl or 4-ethyl-piperazinyl group and pharmaceutically acceptable salts thereof which comprises reacting a compound of the general Formula II  (* CHEMICAL STRUCTURE *) (II) wherein R1 and R2 stand for halogen, for an aliphatic acyloxy group containing 2 to 6 carbon atoms and optionally substituted by halogen, or for an aromatic acyloxy group containing 7 to 11 carbon atoms with a piperazine derivative of the general Formula III  (* CHEMICAL STRUCTURE *) (III)  wherein R3 stands for hydrogen, methyl or ethyl or a salt thereof and subjecting the compound of the general Formula IV  (* CHEMICAL STRUCTURE *) (IV) thus obtained wherein R, R1 and R2 are as stated above to hydrolysis after or without isolation and if desired converting the compound of the general Formula I thus obtained into a salt thereof or setting free the same from its salt. The compounds of the general Formula I are known antibacterial agents.
Patent FI-286774-A (FI)
Inventor: DE LA BURDE R Z
IPC: A24B3/18
Filed: 1974-10-01
Abstract: A process for expanding tobacco is provided which employs liquid carbon dioxide as the expansion agent. Tobacco is contacted with liquid carbon dioxide to thoroughly impregnate the tobacco with the liquid carbon dioxide. The carbon dioxide impregnated tobacco is maintained at a temperature no lower than -2 DEG  C. and under conditions of temperature and elevated pressure such that all or substantially all of the carbon dioxide which is in contact with the tobacco is in liquid form. After the impregnation has been completed, any excess liquid carbon dioxide which may be present with the tobacco may be removed from the tobacco. The elevated pressure is then reduced in order to convert the liquid carbon dioxide to solid carbon dioxide within the tobacco structure. The resulting solid carbon dioxide-containing tobacco is then subjected to conditions of temperature and pressure, preferably by rapid heating at atmospheric pressure, such that the solid carbon dioxide is vaporized and the tobacco is thereby expanded. Apparatus for carrying out the above described process is also provided.
Patent FI-791491-A (FI)
Inventor: KYLMAENEN PASI
IPC: B27L11/02
Filed: 1979-05-10
Abstract: Apparatus for piece-chopping wood includes rotary blade apparatus accommodated within a housing including a helical, screw-like blade member having a conical outer configuration which increases in diameter in the direction in which the wood is fed, the outer edge of the helical blade member being shaped to function as a cutting blade whereby wood fed through a feed hopper into the housing is chopped into relatively large size pieces which are then discharged through a tube communicating with the housing. The housing has an interior fluted guiding surface which is associated with the blade member whereby the wood fed thereto is drawn inwardly towards the blade. At least one counter-blade may be fixed to the interior surface of the housing in the region of the outer edge of the blade member.
Patent FI-800210-A (FI)
Inventor: PETER GERHARD
IPC: B65D65/38
Filed: 1980-01-24
Abstract: In a method for producing a joint between tubular casings, a piece of joining film is bonded and/or sealed, from outside, in a manner proof against against hot moisture around two adjacent tubular casing end pieces which are to be joined together, and the joined tubular casings are used as packaging material.
Patent FI-841508-A (FI)
Inventor: ZIERENBERG BERND
IPC: A61K31/415
Filed: 1984-04-16
Abstract: A novel divisible delayed release pharmaceutical tablet, wherein the rate of release of active ingredient is independent of the size and nature of the total surface area, and the fragments of which have the same characteristics of release of active ingredient as the undivided tablet.
Patent FI-843186-A (FI)
Inventor: POSSIS ZINON C
IPC: A61F2/06
Filed: 1984-08-13
Abstract: A vascular graft is used to supply blood to one or more coronary artery branches. The vascular graft has an elongated U-shaped tubular body providing a continuous passage for carrying blood from a high pressure blood supply to a blood receiver. One or more openings in the body allow blood to flow into the coronary artery branches. The flow and pressure of the blood in the passage is controlled by a restriction providing a Venturi passage located remote from the inlet end of the tubular body. The restriction is reinforced with an annular sleeve to maintain a desired cross sectional area and length of the Venturi passage. The pressure differential between the blood supply and blood receiver maintains continuous and adequate blood flow at a desired pressure in the body passage and provides a continual supply of blood for the coronary artery branches.
Patent FI-855180-A (FI)
Inventor: YAMAMOTO SUSUMU
IPC: A01N47/44
Filed: 1985-12-30
Abstract: A pyrazolesulfonamide derivative represented by Formula (I): <CHEM> wherein R represents a hydrogen atom or a methyl group; X represents a hydrogen atom or a fluorine atom. The compound is useful as a herbicide having not only excellent killing effect on weeds but also the selectivity on certain crops. Useful processes for synthesizing the compound are also disclosed.
Patent FI-863186-A (FI)
Inventor: SHAMI A SAID EL
IPC: G01N33/53
Filed: 1986-08-05
Abstract: The invention provides a method for measuring the concentration of free testosterone ligand in a biological fluid in the presence of bound ligand and endogenous binding proteins, without disturbing the equilibrium between free ligand and protein-bound ligand, which method comprises   (a) incubating, in the absence of salicylate, 2,4-dinitrophenol and 8-anilino-1-naphthalenesulfonic acid, a sample of the biological fluid with (i) a ligand analog tracer which, due to its chemical structure, does not bind to some of the endogenous binding proteins but does bind to at least one other endogenous binding protein, (ii) a concentration of a specific ligand binder having an affinity constant and selectivity for the free ligand such that the equilibrium between free ligand and protein-bound ligand is not disturbed and (iii) a concentration of sulfobromophthalein (SBP) that inhibits the binding of the ligand analog tracer to said at least one other endogenous binding protein sufficient to block reaction between the ligand analog tracer and said at least one other endogenous binding protein without displacing ligand from protein-bound ligand; (b) separating the ligand analog tracer bound to the specific ligand binder from unbound tracer; and (c) determining the concentration of free ligand in said biological fluid.
Patent FI-873272-A (FI)
Inventor: PLATT BRIAN LAURENCE
IPC: A23D7/02
Filed: 1987-07-27
Abstract: A low fat spread which is a water-in-oil emulsion comprising a continuous fat phase and a dispersed aqueous phase, the aqueous phase comprising at least 8% weight of one or more proteins derived from milk, and from 0.l to l.2 % by weight of a modified starch, the fat phase constituting l8-35% by weight of the total weight of the low fat spread.
Patent FI-892892-A (FI)
Inventor: HONEGGER WERNER
IPC: B65H39/075
Filed: 1989-06-13
Abstract: Attached to the rotating draw element (16) are fastening arrangements (20), on each of which a saddle-type rack (12) is arranged. The walls (42, 44) of these racks (12) bound pocket-type receiving parts (46) in the region of the effective conveying route. The printing products (14) fed in by the first feeder (22) are each introduced into a receiving part (46) and opened by an opening apparatus so that the printing product (14'), fed in by the second feeder (22'), can be inserted into the first opened printing product (14). The printing products (14, 14'), inserted into one another in this manner, are picked up by grippers (28) of the outgoing conveyor (24) and are led away. It is also possible for the opening apparatus to be switched off so that the printing products (14, 14'), fed in by both feeders (22, 22'), come to rest adjacently in the receiving parts (46), which enables the printing products (14, 14') to be collated. Furthermore, the printing products (14) can also be fed in by the feeders (22, 22') with their open side at the front, the latter being opened by means of the opening devices (36) and placed astride the saddle-type racks (12). The printing products (14), lying on top of each other having been assembled in this manner, are picked up by the outgoing conveyor (24) and are transported away. 
<IMAGE>
Patent FI-911462-A (FI)
Inventor: CARLISLE WILLIAM DANIEL
IPC: C10N30/04
Filed: 1991-03-26
Abstract: A lubricating oil soluble compound suitable for use as a dispersant additive is obtainable by reacting at elevated temperature a polyepoxide with a dispersant having at least one reactive nitrogen-containing moiety. Intermediates of the general formula IV <CHEM> where Y min  is a derived from the reaction of the polyeyoxide with reactive nitrogen-containing moieties (i.e. primary or secondary amines) are novel. The process for preparing the lubricating oil soluble compounds comprises at least 2 sequential steps. Lubricating oil compositions comprise a major proportion of lubricating oil and a minor proportion of the lubricating oil soluble compounds. <IMAGE>
Patent FI-913022-A (FI)
Inventor: AL-DEEN HISSAM
IPC: F16D55/32
Filed: 1991-06-20
Abstract: In a lubricating system for a brake disc (18), whose brake linings have grooves (44) which run essentially radially and have oil flowing through them from the inside to the outside and to which, radially externally an oil collecting channel (50) connects, from which the oil flows out via at least one outlet channel (52, 60), the oil flow through the grooves (44) can become turbulent at high speeds, adversely affecting the lubrication of the break linings. In order to control the oil flow through the grooves (44) it is proposed to restrict the outlet channel (52, 60) so that an overpressure is produced in the oil collecting channel (50). 
<IMAGE>
Patent FI-920793-A (FI)
Inventor: HALONEN HARRI
IPC: H04B7/26
Filed: 1992-02-24
Abstract: PCT No. PCT/FI92/00367 Sec. 371 Date Oct. 20, 1993 Sec. 102(e) Date Oct. 20, 1993 PCT Filed Dec. 31, 1992 PCT Pub. No. WO93/17506 PCT Pub. Date Sep. 2, 1993.The invention relates to a method for controlling base station transmitters in a cellular system, such as a GSM system, the base station comprising at least two transmitters (TX1 . . . TX4) transmitting on at least one control carrier and at least one traffic carrier, wherein the power transmitted on the traffic carrier is on the average lower than the power transmitted on the control carrier. In order to improve the overall life expectancy of the transmitters, at least the transmitter transmitting on the control carrier is changed constantly. (FIG.
Patent FI-930695-A (FI)
Inventor: LIE TORE
IPC: A47C1/024
Filed: 1993-02-17
Abstract: A straight-type torsion spring, put together from the two ends, which ends can rotate relative to each other against the force of the torsion spring, where the torsion spring 5 comprises at least four identical torsion rods, which, in the horizontal plane, are delimited by one another along the whole of their length, thereby exploiting the relatively large angle of rotation of the dimensionally small torsion rods, combined with the full rotational force of the torsion spring rods, which torsion spring rods are each rotated in a screw- like manner when the spring is activated. An adjustable fixing device for a chair, preferably an office chair, comprising a torsion spring of the above-defined type, a frame for the seat 1, a frame for the backrest 2 and a fastening plate 3, a tilt lever 9, which is fastened in a tube, the other end of which is fastened in the other end of the torsion spring 5, whilst the upper end of the lever 9 is joined by a hinge joint to the front part of the frame 1 of the seat, the rear part of which is joined by a hinge joint to the frame 2 of the backrest of the seat, to the rear end of which frame the backrest of the seat is fastened, and whilst the front part of the frame 2 of the backrest is joined by a hinge joint to the plate 3, the position of which hinge joint 12 is adjustable, and thereby allows adjustment of the angle of the frame for the backrest of the seat. <IMAGE>
Patent FI-930799-A (FI)
Inventor: JEPPESEN LONE
IPC: C07D277/62
Filed: 1993-02-23
Abstract: Piperazinyl derivatives of the general formula I   <IMAGE> (I) wherein R1 represents substituted phenyl, 1- or 2-diazanaphthyl, azadiazanaphtyl or diazanaphtyl groups; n is 1, 2, 3 or 4; X is -O- or  <IMAGE>   wherein R2 is hydrogen, C1-6-alkyl or C3-8-cycloalkyl; Y is =O or =S or =NZ wherein Z is hydrogen, C1-6-alkyl or -CN and R3 is selected from a group consisting of various structures have been found to exhibit high affinity for various receptor subtypes including the 5-HT2 receptor, the 5-HT1A receptor, the alpha1 receptor the dopamine receptor or a combination of these and may therefore be useful for treating CNS system, cardiovascular system and gastrointestinal disorders.